Spontaneous pregnancy during ulipristal acetate treatment of giant uterine leiomyoma
| Autor: | J. Cerkez Habek, I. Hrgovic, Zlatko Hrgovic, Dubravko Habek, Dario Gulin, S. Jerkovic Gulin |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
medicine.medical_treatment Population 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Ulipristal acetate Spontaneous conception Progesterone receptor medicine Pharmacology (medical) Emergency contraception 030212 general & internal medicine education Pharmacology Gynecology Pregnancy education.field_of_study 030219 obstetrics & reproductive medicine Uterine leiomyoma Obstetrics business.industry medicine.disease ulipristil acetate leyomioma fibroids pregnancy Leiomyoma chemistry business |
| Popis: | WHAT IS KNOWN AND OBJECTIVE: Ulipristal acetate a progesterone receptor modulator pharmacologically inhibits endometrial proliferation and thereby prevents pregnancy. It is primarily used as emergency contraception but also for the treatment of fibroids in women of reproductive age. There have been no published cases of pregnancy while on therapy with ulipristal acetate. CASE DESCRIPTION: In this article we present a case report of spontaneous pregnancy during ulipristal acetate therapy. WHAT IS NEW AND CONCLUSION: To our knowledge this is the first patient with spontaneous conception while on ulipristal acetate treatment. There were no drug-related complications and the pregnancy resulted in the delivery of a healthy baby. (c) 2017 John Wiley & Sons Ltd. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|